PMC:7189872 / 3860-3965 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"65","span":{"begin":95,"end":104},"obj":"Species"}],"attributes":[{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T14","span":{"begin":95,"end":99},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T35","span":{"begin":54,"end":61},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":54,"end":61},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T68","span":{"begin":95,"end":104},"obj":"SP_7"},{"id":"T54733","span":{"begin":95,"end":104},"obj":"SP_7"}],"text":"Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2."}